Published • loading... • Updated
10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer Care
Summary by PR Newswire
2 Articles
2 Articles
10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer Care
/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today...
·Chicago, United States
Read Full Article
10x Genomics, Inc. (TXG) Stock Analysis: Navigating a Pioneering Path in Health Information Services
10x Genomics, Inc. (NASDAQ: TXG), a leader in the health information services industry, is a company worth examining for investors interested in innovative technologies that drive biological research. With a market capitalization of $5.83 billion, the company is renowned for its advanced platforms and software that enable detailed analysis of biological systems, serving a global clientele across the academic, government, and biopharmaceutical se…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
